首页> 美国卫生研究院文献>Molecular Pain >Neuropathic pain and Kv7 voltage-gated potassium channels: Thepotential role of Kv7 activators in the treatment of neuropathicpain
【2h】

Neuropathic pain and Kv7 voltage-gated potassium channels: Thepotential role of Kv7 activators in the treatment of neuropathicpain

机译:神经性疼痛和Kv7电压门控性钾通道:Kv7激活剂在神经性疾病治疗中的潜在作用痛

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neuropathic pain conditions severely and chronically affect the quality of life in a large human population, but the pain conditions are not adequately managed due to poor understanding of their underlying mechanisms. There is a pressing need for further research into this field to help develop effective and nonaddictive medications to treat neuropathic pain. This article first describes general clinical classification of pain, types and symptoms of neuropathic pain, and current practices of clinical management for neuropathic pain. This is followed by a discussion of various cellular and molecular mechanisms responsible for the development and maintenance of neuropathic pain. In this review, we highlight the loss of function of Kv7 voltage-gated potassium as a mechanism of neuropathic pain and the potential use of Kv7 channel activator as subsequent treatment.
机译:神经性疼痛状况严重且长期影响着大批人口的生活质量,但由于对疼痛的潜在机制了解不足,因此无法对疼痛状况进行适当的管理。迫切需要对该领域进行进一步研究,以帮助开发有效且非成瘾的药物来治疗神经性疼痛。本文首先介绍了疼痛的一般临床分类,神经性疼痛的类型和症状,以及神经性疼痛的临床管理的当前实践。接下来是引起神经性疼痛发展和维持的各种细胞和分子机制的讨论。在这篇综述中,我们着重介绍了Kv7电压门控钾作为神经性疼痛机制的功能的丧失以及Kv7通道激活剂作为后续治疗的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号